| Name | Cvs Pharmacy #16346 |
|---|---|
| Organization Name | Woodward Detroit Cvs Llc |
| Location | 8043 Challis Rd, Brighton, Michigan 48116 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (810) 229-4264 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Treatment of ductal carcinoma in situ (DCIS), a group of abnormal cells confined to the breast ducts, varies widely in the United States. Treatment ranges from potential over-treatment with aggressive surgical therapy to possible under-treatment by not providing radiation.
The World Health Organization Western Pacific Region, in collaboration with international partner agencies, is seeking to scale up HIV/AIDS prevention and control activities in line with the goal of universal access for HIV/AIDS treatment throughout Asia and the Pacific by 2010.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
When it infects the lungs, the Legionnaire's bacterium Legionella pneumophila causes acute pneumonia. The pathogen's modus operandi is particularly ingenious: it infiltrates deliberately into cells of the human immune system and injects a host of proteins which then interfere in the normal cellular processes. Scientists from the Max Planck Institute of Molecular Physiology in Dortmund have now discovered how Legionella reprogrammes the cells to ensure its own survival and to propagate. They examined a protein used by the pathogen to divert the material transport within the cells for its own purposes.
› Verified 4 days ago
| NPI Number | 1740202415 |
| Organization Name | WOODWARD DETROIT CVS LLC |
| Doing Business As | CVS PHARMACY #16346 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 8043 Challis Rd, Brighton, MI 48116 |
| Phone Number | 810-229-4264 |
News Archive
Treatment of ductal carcinoma in situ (DCIS), a group of abnormal cells confined to the breast ducts, varies widely in the United States. Treatment ranges from potential over-treatment with aggressive surgical therapy to possible under-treatment by not providing radiation.
The World Health Organization Western Pacific Region, in collaboration with international partner agencies, is seeking to scale up HIV/AIDS prevention and control activities in line with the goal of universal access for HIV/AIDS treatment throughout Asia and the Pacific by 2010.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
When it infects the lungs, the Legionnaire's bacterium Legionella pneumophila causes acute pneumonia. The pathogen's modus operandi is particularly ingenious: it infiltrates deliberately into cells of the human immune system and injects a host of proteins which then interfere in the normal cellular processes. Scientists from the Max Planck Institute of Molecular Physiology in Dortmund have now discovered how Legionella reprogrammes the cells to ensure its own survival and to propagate. They examined a protein used by the pathogen to divert the material transport within the cells for its own purposes.
› Verified 4 days ago
News Archive
Treatment of ductal carcinoma in situ (DCIS), a group of abnormal cells confined to the breast ducts, varies widely in the United States. Treatment ranges from potential over-treatment with aggressive surgical therapy to possible under-treatment by not providing radiation.
The World Health Organization Western Pacific Region, in collaboration with international partner agencies, is seeking to scale up HIV/AIDS prevention and control activities in line with the goal of universal access for HIV/AIDS treatment throughout Asia and the Pacific by 2010.
Lipocine Inc. announced today that in addition to its issued patents involving oral testosterone, it has recently filed two new patent applications in support of its oral testosterone product for hypogonadism, also known as low testosterone (low T). These applications cover Lipocine's novel oral testosterone product (LPCN 1021) being developed to overcome the issues with currently marketed topical, parenteral, and transdermal testosterone products.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
When it infects the lungs, the Legionnaire's bacterium Legionella pneumophila causes acute pneumonia. The pathogen's modus operandi is particularly ingenious: it infiltrates deliberately into cells of the human immune system and injects a host of proteins which then interfere in the normal cellular processes. Scientists from the Max Planck Institute of Molecular Physiology in Dortmund have now discovered how Legionella reprogrammes the cells to ensure its own survival and to propagate. They examined a protein used by the pathogen to divert the material transport within the cells for its own purposes.
› Verified 4 days ago
Physical Address Type: Durable Medical Equipment & Medical Supplies Supplier Location: 455 E Grand River Ave, Brighton, Michigan 48116 Phone: (888) 246-7667 | |
Rite Aid Pharmacy #04314 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8701 W Grand River Ave, Brighton, Michigan 48116 Phone: (810) 220-5840 | |
Cvs Pharmacy #08204 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 106 W Grand River Ave, Brighton, Michigan 48116 Phone: (810) 220-8804 | |
Cvs Pharmacy #16346 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8043 Challis Rd, Brighton, Michigan 48116 Phone: (810) 229-4264 | |
Cvs Pharmacy #08111 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5757 Whitmore Lake Rd, Brighton, Michigan 48116 Phone: (810) 229-9772 |